Price target
9.150.000.00%
The 10 analysts offering 1 year price forecasts for TRVI have a max estimate of — and a min estimate of —.
Analyst rating
Based on 10 analysts giving stock ratings to TRVI in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
TRVI EPS for the last quarter is −0.13 USD despite the estimation of −0.12 USD. In the next quarter EPS is expected to reach −0.12 USD. Track more of Trevi Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Trevi Therapeutics, Inc. revenue is expected to reach 0.00 USD. Check out Trevi Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, TRVI price target is 9.15 USD with a max estimate of 21.00 USD and a min estimate of 6.00 USD. Check if this forecast comes true in a year, meanwhile watch Trevi Therapeutics, Inc. stock price chart and keep track of the current situation with TRVI news and stock market news.
We've gathered opinions of 10 analysts rating TRVI stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.